• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    iHuman Inc. Announces Third Quarter 2023 Unaudited Financial Results

    12/28/23 1:12:00 AM ET
    $IH
    Other Consumer Services
    Real Estate
    Get the next $IH alert in real time by email

    BEIJING, Dec. 28, 2023 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2023.

    (PRNewsfoto/iHuman Inc.)

    Third Quarter 2023 Highlights

    • Revenues were RMB261.5 million (US$35.8 million), compared with RMB251.5 million in the same period last year.
    • Gross profit was RMB186.6 million (US$25.6 million), compared with RMB177.1 million in the same period last year.
    • Operating income was RMB40.4 million (US$5.5 million), compared with RMB38.5 million in the same period last year.
    • Adjusted operating income[1] was RMB42.9 million (US$5.9 million), compared with RMB42.5 million in the same period last year.
    • Net income was RMB51.9 million (US$7.1 million), compared with RMB39.5 million in the same period last year.
    • Adjusted net income[1] was RMB54.4 million (US$7.5 million), compared with RMB43.5 million in the same period last year.
    • Average total MAUs[2] reached a record-high of 25.36 million, a year-over-year increase of 22.9%.

    Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, "We are excited to announce another strong quarter of results with average total MAUs increasing an impressive 22.9% year-over-year to reach another record-high of 25.36 million, which I believe reflects our unwavering commitment to delivering exceptional experiences and value to our users."

    "During the quarter, we focused squarely on strengthening our product portfolio in both domestic and international markets. Domestically, we further refined our industry-leading offerings with improvements to both content and functionality. We launched two additional exciting themes for iHumanpedia, "Earth Treasure Hunt" and "Animal Architects," which were specifically designed to nurture the scientific curiosity of children. As we continue to expand our content library, we are constantly developing innovative ways to engage users and enrich their experiences. For example, we hosted popular science competitions that encouraged participants to create science-themed short-form videos, among which the most outstanding entries would be featured on the iHumanpedia app. These initiatives as well as others we have rolled out all received enthusiastic feedback from users and are encouraging more active participation and contributing to a more vibrant community."

    "Internationally, we enhanced the appeal of our products by rolling out popular seasonal themes that resonate with overseas users. For example, we launched a Halloween pack for Aha World which offered a wide selection of classic Halloween costumes and immersive, spooky experiences that were highly popular among younger audiences. Aha World has recently surged to rank among the top three most popular children's apps on Apple's app store in the U.S. These ongoing efforts to drive product excellence are increasingly earning us international recognition. Notably, we were awarded the prestigious w3 Gold Award in the Mobile Apps & Sites - Family & Kids category, for bekids Reading. With thousands of entries from across the globe annually, the w3 Awards is one of the most prestigious honors in digital design, marketing, media and technology that recognizes the industry's best across user experiences, content, and creativity. Winning the w3 Gold Award represents a substantial recognition of the high quality and innovative nature of our products and marks another significant milestone for us as a company specialized in child intellectual development."

    "Our smart devices business also continued to make solid progress with the launch of the second generation of Logic Pal, an easy-to-operate device designed to facilitate early childhood word recognition, pronunciation, and cognitive growth through pluggable cards and interactive activities. To diversify our offerings, we have also launched Diandian Storyteller, a portable device that empowers children to enhance their storytelling abilities and expand their imagination."

    "We are truly encouraged by the momentum across our entire portfolio and take great pride in our team's resolve and consistent execution. I am excited about the opportunities that lie ahead and the potential for our continuous growth and innovation," concluded Dr. Dai.

    Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, "With an unwavering focus on long-term growth, we continue to invest in refining our product lineup while steadily expanding our overseas presence. Our dedication and relentless efforts to the business have enabled us to achieve another solid quarter. We once again recorded revenue growth on both an annual and sequential basis, marking our seventh consecutive profitable quarter. This remarkable achievement has further solidified our financial position, establishing a solid foundation for our future expansion."

    "While we continue to advance our strategic priorities, we are also actively engaged in public initiatives that aim to inspire young minds and support their holistic development. Since the launch of bekids Coding, we have been enthusiastic participants in the Hour of Code, a global initiative that introduces tens of millions of students worldwide to computer science and programming through free coding tutorials and activities. In 2022, several elementary schools across the United States completed our Hour of Code challenge and shared their experiences on social media. This year, we are thrilled to participate in the Hour of Code initiative again, aiming to further inspire and engage children worldwide. Our participation in such events has strengthened our brand profile and influence internationally. As we move forward, our commitment to managing a strong portfolio of products and driving business growth will remain central to our strategy, ensuring sustainable development and creating more value for our shareholders."

    Third Quarter 2023 Unaudited Financial Results

    Revenues

    Revenues were RMB261.5 million (US$35.8 million), an increase of 4.0% from RMB251.5 million in the same period last year, primarily driven by user expansion and enhanced user engagement.

    Average total MAUs for the quarter were 25.36 million, an increase of 22.9% year-over-year from 20.63 million in the same period last year. The number of paying users[3] was 1.54 million.

    Cost of Revenues

    Cost of revenues was RMB74.9 million (US$10.3 million), maintaining approximately the same level of RMB74.4 million in the same period last year.

    Gross Profit and Gross Margin

    Gross profit was RMB186.6 million (US$25.6 million), an increase of 5.4% from RMB177.1 million in the same period last year. Gross margin was 71.4%, compared with 70.4% in the same period last year.

    Operating Expenses

    Total operating expenses were RMB146.2 million (US$20.0 million), an increase of 5.5% from RMB138.6 million in the same period last year.

    Research and development expenses were RMB66.2 million (US$9.1 million), a decrease of 7.9% from RMB71.9 million in the same period last year, primarily due to payroll-related cost savings and decreased outsourcing expenses as a result of the continued optimization of our operational efficiency.

    Sales and marketing expenses were RMB54.0 million (US$7.4 million), an increase of 29.6% from RMB41.7 million in the same period last year, primarily due to increased strategic spending on promotional activities.

    General and administrative expenses were RMB26.1 million (US$3.6 million), compared with RMB25.0 million in the same period last year.

    Operating Income

    Operating income was RMB40.4 million (US$5.5 million), compared with RMB38.5 million in the same period last year.

    Excluding share-based compensation expenses, adjusted operating income was RMB42.9 million (US$5.9 million), compared with RMB42.5 million in the same period last year.

    Net Income

    Net income was RMB51.9 million (US$7.1 million), an increase of 31.5% from RMB39.5 million in the same period last year.

    Adjusted net income was RMB54.4 million (US$7.5 million), an increase of 25.1% from RMB43.5 million in the same period last year.

    Basic and diluted net income per ADS were RMB0.98 (US$0.13) and RMB0.95 (US$0.13), respectively, compared with RMB0.74 and RMB0.73 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.

    Adjusted diluted net income per ADS was RMB0.99 (US$0.14), compared with RMB0.80 in the same period last year.

    Deferred Revenue and Customer Advances

    Deferred revenue and customer advances were RMB320.4 million (US$43.9 million) as of September 30, 2023, compared with RMB379.1 million as of December 31, 2022.

    Cash, Cash Equivalents and Time Deposits

    Cash, cash equivalents and time deposits were RMB1,174.2 million (US$160.9 million) as of September 30, 2023, compared with RMB1,050.0 million as of December 31, 2022.

    [1] "Adjusted operating income" and "adjusted net income" exclude share-based compensation expenses. Please see "Non-GAAP Financial Measures" and "Unaudited Reconciliation of GAAP and non-GAAP Results" at the end of this press release.

    [2] "Average total MAUs" refers to the monthly average of the sum of the MAUs of each of the Company's apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.

    [3]  "Paying users" refers to users who paid subscription fees for premium content on any of the Company's apps during a specific period; a user who makes payments across different apps using the same registered account is counted as one paying user, and a user who makes payments for the same app multiple times in the same period is counted as one paying user.

    Extension of Share Repurchase Program

    Given its confidence in the Company's business prospects, the board of directors (the "Board") has authorized another extension of the Company's existing share repurchase program, as authorized in December 2021 and extended in December 2022, by twelve months through December 31, 2024. Pursuant to the extended share repurchase program, the Company's proposed repurchases may be made from time to time through open market transactions at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on the market conditions and in accordance with applicable rules and regulations. The timing and dollar amount of repurchase transactions will be subject to the Securities and Exchange Commission Rule 10b-18 and Rule 10b5-1 requirements. The Board will continue to review the extended share repurchase program periodically, and may authorize adjustments to its terms and size. The Company expects to continue to fund the repurchases under the extended share repurchase program with its existing cash balance.

    Exchange Rate Information

    The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of September 29, 2023, which was RMB7.2960 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.

    Non-GAAP Financial Measures

    iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman's management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company's current operating performance and prospects in the same manner as management does, if they so choose.

    Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.

    Safe Harbor Statement

    This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates"  and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman's growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman's filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    About iHuman Inc.

    iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines over two decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity, and foster their natural interest in traditional Chinese culture. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

    For more information about iHuman, please visit https://ir.ihuman.com/. 

    For investor and media enquiries, please contact:

    iHuman Inc.

    Mr. Justin Zhang

    Investor Relations Director

    Phone: +86 10 5780-6606

    E-mail: [email protected] 

    Christensen

    In China

    Ms. Alice Li

    Phone: +86-13381389369

    E-mail: [email protected]  

    In the US

    Ms. Linda Bergkamp

    Phone: +1-480-614-3004

    E-mail: [email protected]  

     

     

    iHuman Inc.

    UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    December 31,



    September 30,



    September 30,



    2022



    2023



    2023



    RMB



    RMB



    US$













    ASSETS











    Current assets











    Cash and cash equivalents 

    1,049,999



    1,037,751



    142,236

    Time deposits

    -



    136,416



    18,697

    Accounts receivable, net

    79,614



    69,381



    9,509

    Inventories, net

    19,127



    13,457



    1,844

    Amounts due from related parties

    2,286



    1,979



    271

    Prepayments and other current assets

    102,765



    83,999



    11,513

    Total current assets

    1,253,791



    1,342,983



    184,070

    Non-current assets











    Property and equipment, net

    9,205



    6,530



    895

    Intangible assets, net

    24,872



    24,093



    3,302

    Operating lease right-of-use assets

    12,782



    4,056



    556

    Long-term investment

    26,333



    26,333



    3,609

    Other non-current assets

    6,416



    7,843



    1,076

    Total non-current assets

    79,608



    68,855



    9,438

    Total assets

    1,333,399



    1,411,838



    193,508













    LIABILITIES











    Current liabilities











    Accounts payable

    24,206



    16,235



    2,225

    Deferred revenue and customer advances

    379,063



    320,438



    43,920

    Amounts due to related parties

    6,944



    10,917



    1,496

    Accrued expenses and other current liabilities

    144,717



    131,722



    18,054

    Current operating lease liabilities

    6,123



    1,818



    249

    Total current liabilities

    561,053



    481,130



    65,944

    Non-current liabilities











    Non-current operating lease liabilities

    2,894



    2,361



    324

    Total non-current liabilities

    2,894



    2,361



    324

    Total liabilities

    563,947



    483,491



    66,268

    SHAREHOLDERS' EQUITY











    Ordinary shares (par value of US$0.0001 per share,

      700,000,000 Class A shares authorized as of December

      31, 2022 and September 30, 2023; 125,122,382 Class A

      shares issued and 121,722,467 outstanding as of

      December 31, 2022; 125,122,382 Class A shares issued

      and
    119,698,967 outstanding as of September 30, 2023;

      200,000,000 Class B shares authorized, 144,000,000

      Class B ordinary shares issued and outstanding as of

      December 31, 2022 and September 30, 2023; 100,000,000

      shares (undesignated) authorized, nil shares

      (undesignated) issued and outstanding as of December 31,

      2022 and September 30, 2023)

    185



    185



    25

    Additional paid-in capital

    1,079,099



    1,086,502



    148,917

    Treasury stock

    (7,123)



    (16,665)



    (2,284)

    Statutory reserves

    7,967



    7,967



    1,092

    Accumulated other comprehensive income

    10,497



    23,895



    3,275

    Accumulated deficit

    (321,173)



    (173,537)



    (23,785)

    Total shareholders' equity

    769,452



    928,347



    127,240

    Total liabilities and shareholders' equity

    1,333,399



    1,411,838



    193,508

     

     

     

    iHuman Inc.

    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    For the three months ended



    For the nine months ended



    September 30,



    June 30,



    September 30,



    September 30,



    September 30,



    September 30,



    September 30,



    2022



    2023



    2023



    2023



    2022



    2023



    2023



    RMB



    RMB



    RMB



    US$



    RMB



    RMB



    US$





























    Revenues

    251,527



    240,993



    261,496



    35,841



    724,813



    767,692



    105,221

    Cost of revenues

    (74,422)



    (70,160)



    (74,871)



    (10,262)



    (214,636)



    (224,667)



    (30,793)





























    Gross profit

    177,105



    170,833



    186,625



    25,579



    510,177



    543,025



    74,428





























    Operating expenses



























    Research and development expenses

    (71,859)



    (63,412)



    (66,168)



    (9,069)



    (246,685)



    (191,253)



    (26,213)

    Sales and marketing expenses

    (41,669)



    (40,564)



    (53,994)



    (7,400)



    (111,105)



    (134,993)



    (18,502)

    General and administrative expenses

    (25,035)



    (25,982)



    (26,070)



    (3,573)



    (79,942)



    (78,787)



    (10,799)

    Total operating expenses

    (138,563)



    (129,958)



    (146,232)



    (20,042)



    (437,732)



    (405,033)



    (55,514)

    Operating income

    38,542



    40,875



    40,393



    5,537



    72,445



    137,992



    18,914

    Other income, net

    9,611



    8,132



    19,507



    2,674



    15,875



    33,721



    4,622

    Income before income taxes

    48,153



    49,007



    59,900



    8,211



    88,320



    171,713



    23,536

    Income tax expenses

    (8,675)



    (6,933)



    (7,984)



    (1,094)



    (13,934)



    (24,077)



    (3,300)

    Net income

    39,478



    42,074



    51,916



    7,117



    74,386



    147,636



    20,236





























    Net income per ADS:



























       - Basic

    0.74



    0.80



    0.98



    0.13



    1.39



    2.79



    0.38

       - Diluted

    0.73



    0.77



    0.95



    0.13



    1.38



    2.70



    0.37





























    Weighted average number of ADSs:



























       - Basic

    53,240,710



    52,804,594



    52,747,426



    52,747,426



    53,341,120



    52,834,352



    52,834,352

       - Diluted

    54,114,651



    54,725,528



    54,772,536



    54,772,536



    54,043,728



    54,753,124



    54,753,124





























    Total share-based compensation expenses included in:



























    Cost of revenues

    77



    70



    67



    9



    180



    235



    32

    Research and development expenses

    2,045



    1,142



    1,160



    159



    3,813



    2,940



    403

    Sales and marketing expenses

    698



    59



    147



    20



    1,040



    585



    80

    General and administrative expenses

    1,187



    1,160



    1,105



    151



    2,963



    3,557



    488





























     

     

     

    iHuman Inc.

    UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS

    (Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

    except for number of shares, ADSs, per share and per ADS data)





    For the three months ended



    For the nine months ended



    September 30,



    June 30,



    September 30,



    September 30,



    September 30,



    September 30,



    September 30,



    2022



    2023



    2023



    2023



    2022



    2023



    2023



    RMB



    RMB



    RMB



    US$



    RMB



    RMB



    US$





























    Operating income

    38,542



    40,875



    40,393



    5,537



    72,445



    137,992



    18,914

    Share-based compensation expenses

    4,007



    2,431



    2,479



    339



    7,996



    7,317



    1,003

    Adjusted operating income

    42,549



    43,306



    42,872



    5,876



    80,441



    145,309



    19,917





























    Net income

    39,478



    42,074



    51,916



    7,117



    74,386



    147,636



    20,236

    Share-based compensation expenses

    4,007



    2,431



    2,479



    339



    7,996



    7,317



    1,003

    Adjusted net income

    43,485



    44,505



    54,395



    7,456



    82,382



    154,953



    21,239





























    Diluted net income per ADS

    0.73



    0.77



    0.95



    0.13



    1.38



    2.70



    0.37

    Impact of non-GAAP adjustments

    0.07



    0.04



    0.04



    0.01



    0.14



    0.13



    0.02

    Adjusted diluted net income per ADS

    0.80



    0.81



    0.99



    0.14



    1.52



    2.83



    0.39





























    Weighted average number of ADSs – diluted

    54,114,651



    54,725,528



    54,772,536



    54,772,536



    54,043,728



    54,753,124



    54,753,124

    Weighted average number of ADSs – adjusted

    54,114,651



    54,725,528



    54,772,536



    54,772,536



    54,043,728



    54,753,124



    54,753,124

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ihuman-inc-announces-third-quarter-2023-unaudited-financial-results-302023148.html

    SOURCE iHuman Inc.

    Get the next $IH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IH

    DatePrice TargetRatingAnalyst
    12/30/2022$3.10Buy
    Citigroup
    More analyst ratings

    $IH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup resumed coverage on iHuman with a new price target

    Citigroup resumed coverage of iHuman with a rating of Buy and set a new price target of $3.10

    12/30/22 8:45:58 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results

    BEIJING, Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Revenues were RMB205.8 million (US$28.9 million), compared with RMB239.4 million in the same period last year.Gross profit was RMB140.6 million (US$19.8 million), compared with RMB163.9 million in the same period last year.Operating income was RMB16.7 million (US$2.3 million), compared

    12/29/25 4:11:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results

    BEIJING, Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenues were RMB200.2 million (US$27.9 million), compared with RMB215.1 million in the same period last year.Gross profit was RMB135.7 million (US$19.0 million), compared with RMB151.7 million in the same period last year.Operating income was RMB19.5 million (US$2.7 million), compared wi

    9/18/25 4:30:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman and Cricket Media Team Up to Launch Reading Stars

    Reading Stars seamlessly merges Cricket's award-winning content with iHuman's cutting-edge technology, creating an entirely new way for children to engage with reading. BEIJING and MCLEAN, Va., Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH), a leading provider of tech‑powered, intellectual development products in China, and Cricket Media, whose magazines have delighted families for more than 50 years, today announced the global launch of Reading Stars. Drawing on iHuman's expertise in content digitalization, edutainment and interactive learning design, along with Cricket Media's extensive library, the app transforms traditional reading resources into a dynamic digital experience that

    9/18/25 4:00:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    SEC Filings

    View All

    SEC Form 6-K filed by iHuman Inc.

    6-K - iHuman Inc. (0001814423) (Filer)

    12/29/25 7:33:02 AM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by iHuman Inc.

    6-K - iHuman Inc. (0001814423) (Filer)

    9/18/25 7:08:02 AM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form 6-K filed by iHuman Inc.

    6-K - iHuman Inc. (0001814423) (Filer)

    6/26/25 7:54:57 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    Financials

    Live finance-specific insights

    View All

    iHuman Inc. Announces Third Quarter 2025 Unaudited Financial Results

    BEIJING, Dec. 29, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights Revenues were RMB205.8 million (US$28.9 million), compared with RMB239.4 million in the same period last year.Gross profit was RMB140.6 million (US$19.8 million), compared with RMB163.9 million in the same period last year.Operating income was RMB16.7 million (US$2.3 million), compared

    12/29/25 4:11:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results

    BEIJING, Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights Revenues were RMB200.2 million (US$27.9 million), compared with RMB215.1 million in the same period last year.Gross profit was RMB135.7 million (US$19.0 million), compared with RMB151.7 million in the same period last year.Operating income was RMB19.5 million (US$2.7 million), compared wi

    9/18/25 4:30:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    iHuman Inc. Announces First Quarter 2025 Unaudited Financial Results

    BEIJING, June 26, 2025 /PRNewswire/ -- iHuman Inc. (NYSE:IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights Revenues were RMB210.4 million (US$29.0 million), compared with RMB235.0 million in the same period last year.Gross profit was RMB143.8 million (US$19.8 million), compared with RMB168.1 million in the same period last year.Operating income was RMB21.6 million (US$3.0 million), compared with

    6/26/25 6:12:00 AM ET
    $IH
    Other Consumer Services
    Real Estate

    $IH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

    SC 13G/A - iHuman Inc. (0001814423) (Subject)

    3/8/22 10:06:04 AM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form SC 13G/A filed by iHuman Inc. (Amendment)

    SC 13G/A - iHuman Inc. (0001814423) (Subject)

    2/14/22 4:13:25 PM ET
    $IH
    Other Consumer Services
    Real Estate

    SEC Form SC 13G filed

    SC 13G - iHuman Inc. (0001814423) (Subject)

    2/16/21 6:11:44 AM ET
    $IH
    Other Consumer Services
    Real Estate